Literature DB >> 12873050

Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus.

M Tiefenthaler1, N Bacher, H Linert, O Mühlmann, S Hofer, N Sepp, A Amberger, F Geisen, G Obermoser, G Konwalinka.   

Abstract

Leukopenia and anaemia are observed in about a fifth of all patients with systemic lupus erythematosus (SLE) and may be due either to the destruction of blood cells or their decreased production. The former may be humoral or cell-mediated or result from apoptosis of peripheral blood cells. Several observations suggest the occurrence of the latter reduced in vitro proliferation of pluripotent bone marrow progenitors from the bone marrow aspirates of SLE patients,reduced counts of CD34+ cells in bone marrow aspirates in SLE patients, apoptosis of lymphopoietic progenitors and apoptosis of bone marrow cells. The aim of our study was to investigate whether humoral factors may induce suppression of haematopoiesis by increased apoptosis of CD34+ cells. For this purpose, we incubated allogeneic CD34+-enriched cells with sera of 18 leukopenic SLE patients. Apoptosis was induced by four of 18 sera. This effect was independent of complement-inhibition and FAS-blockade. Although reduced proliferation of autologous pluripotent bone marrow progenitors has been attributed to an IgG serum inhibitor, removal of IgG from these four proapoptotic sera had no effect on apoptosis of allogeneic CD34+ cells. The proapoptotic effect was associated with high titres of anti-dsDNA antibodies and low haemoglobin concentrations, but not with high titres of antinuclear antibodies, TNF-alpha and IFN-alpha of the sera tested.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873050     DOI: 10.1191/0961203303lu423oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  8 in total

1.  Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway.

Authors:  Dhanesh Pitidhammabhorn; Surasak Kantachuvesiri; Kitti Totemchokchyakarn; Yindee Kitiyanant; Sukathida Ubol
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

2.  Nuclear-targeting autoantibodies induced nuclear PARP cleavage accompanied by more pronounced decrease of peripheral white blood cells than Ro/SSA and La/SSB antigen-targeting autoantibodies.

Authors:  Ingrid Böhm
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

3.  Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.

Authors:  Peter E Westerweel; Remco K M A C Luijten; Imo E Hoefer; Hein A Koomans; Ronald H W M Derksen; Marianne C Verhaar
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

Review 4.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

5.  Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus - an additional mechanism to increased autoantigen load?

Authors:  A A Bengtsson; G Sturfelt; B Gullstrand; L Truedsson
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 6.  Endothelial progenitor cell dysfunction in rheumatic disease.

Authors:  Peter E Westerweel; Marianne C Verhaar
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

7.  Abnormal surface markers expression on bone marrow CD34+ cells and correlation with disease activity in patients with systemic lupus erythematosus.

Authors:  Ling-Yun Sun; Kang-Xin Zhou; Xue-Bing Feng; Hua-Yong Zhang; Xue-Qin Ding; Ou Jin; Li-Wei Lu; Chak-Sing Lau; Ya-Yi Hou; Le-Ming Fan
Journal:  Clin Rheumatol       Date:  2007-04-20       Impact factor: 2.980

8.  Altered frequency of peripheral B-cell subsets and their correlation with disease activity in patients with systemic lupus erythematosus: A comprehensive analysis.

Authors:  Yanxia Peng; Fengbiao Guo; Shuzhen Liao; Huanjin Liao; Haiyan Xiao; Lawei Yang; Hua-Feng Liu; Qingjun Pan
Journal:  J Cell Mol Med       Date:  2020-09-12       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.